# Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients

> **NCT06917950** · PHASE1,PHASE2 · RECRUITING · sponsor: **Mansoura University** · enrollment: 46 (estimated)

## Conditions studied

- Kidney Failure,Chronic
- Anemia in End Stage Renal Disease
- Depression Anxiety Disorder

## Interventions

- **DRUG:** Roxadustat
- **DRUG:** Conventional Anemia Management

## Key facts

- **NCT ID:** NCT06917950
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-11-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917950, "Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06917950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*